Patent 5875776 Issued on March 2, 1999. Estimated Expiration Date: April 9, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
128/203.15, Particulate treating agent carried by breathed gas128/203.12, Means for mixing treating agent with respiratory gas128/203.21Means broken or pierced to supply treating agent
A dry powder inhaler includes a housing, a dosing cartridge, and a spacer. Within the housing are a source of pressurized gas, a pressure gauge, a metered valve controlled by a trigger, a safety valve, and an electrostatic charger also controlled by the trigger. The dosing cartridge contains individual doses in airtight cells with one or more openings, each covered by an airtight coversheet. The system uses gas pressure or a penetration device to rupture one of the airtight cells, suspending the powder and directing it to a spacer for subsequent inhalation. The electrostatic charger discharges on the spacer, establishing an electrostatic charge thereon. The spacer includes a non-stick lining. The housing is designed so that it can retract into the spacer.
Other References
Barnes, Peter J., "Inhaled Glucocorticoids For Asthma." The New England Journal of Medincine 322 (13): 868-875 (1995)
Bell et al., "Dry Powder Aerosols I: A New Powder Inhalation Device." Journal of Pharmaceutical Sciences 60 (10) : 1559-1564 (1971)
Cicerone et al., "Stratosphric Ozone Destruction by Man-Made Clorofluoromethanes." Science 185: 1165-1167 (1974)
Clay et al., "Assessment Of Jet Nebulisers For Lung Aerosol Therapy." The Lancet:592-594 (1983)
Clay et al., "Factors influencing the size distribution of aerosols from jet nebulisers." Thorax 38: 755-759 (1983)
Cockcroft et al., "Importance of Evaporative Water Losses During Standardized Nebulized Inhalation Provocation Tests." Chest 96(3) : 505-508 (1989)
Hallworth, G. W., "The formulation and evaluation of pressurised metered-dose inhalers." In Drug Delivery to the Respiratory Tract (Garderton and Jones, eds.) Ellis Horwood, Engl., pp. 87-118 (1987)
Jones, Kevin, "New delivery system for asthma drugs." The Practitioner 233: 265-267 (1989)
Kelsen et al., "Airborne Contamination of Fine-Particle Nebulizers." JAMA 237 (21) : 2311-2314 (1977)
Kongerud et al., "Room temperature influences output from the Wright jet nebulizer." Eur. Respir. J. 2: 681-684 (1989)
Newman, Stephen P., "Therapeutic aerosols." In Aerosols and the Lung:Clinical and Experimental Aspects. (Clarke and Pavia, eds.) Butterworths, Chapter 9. (1987)
Popa et al., "Domiciliary metaproterenol nebulization: A bacteriologic survey." J. Allergy Clin. Immunol 82 (2) : 231-236 (1988)
Ribeiro and Wiren, "Comparison of Bricanyl Turbuhaler and Berotec dry powder inhaler." Allergy 45: 382-385 (1990)
Sterk et al., "Physical Properties Of Aerosols Produced By Several Jet-And Ultrasonic Nebulizers." Bull. Eur. Physiopathol. Respir. 20: 65-72 a91984)
Tillery et al., "Generation and Characterization of Aerosols and Vapors for Inhalation Experiments." Environmental Health Perspectives 16: 25-40 (1976)
Witek and Schachter, Detection of Sulfur Dioxide in Bronchodilator Aerosols. Chest 86(4) : 592-594 (1984)
Wetterlin, Kjell, "Turbuhaler: A New Powder Inhaler for Administration of Drugs to the Airways." Pharmaceutical Research 5 (8) : 506-508 (1988
April 9, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
